PMID- 38311057 OWN - NLM STAT- Publisher LR - 20240204 IS - 2233-6087 (Electronic) IS - 2233-6079 (Linking) DP - 2024 Feb 1 TI - Reducing Oxidative Stress and Inflammation by Pyruvate Dehydrogenase Kinase 4 Inhibition Is Important in Prevention of Renal Ischemia-Reperfusion Injury in Diabetic Mice. LID - 10.4093/dmj.2023.0196 [doi] AB - BACKGROUND: Reactive oxygen species (ROS) and inflammation are reported to have a fundamental role in the pathogenesis of ischemia-reperfusion (IR) injury, a leading cause of acute kidney injury. The present study investigated the role of pyruvate dehydrogenase kinase 4 (PDK4) in ROS production and inflammation following IR injury. METHODS: We used a streptozotocin-induced diabetic C57BL6/J mouse model, which was subjected to IR by clamping both renal pedicles. Cellular apoptosis and inflammatory markers were evaluated in NRK-52E cells and mouse primary tubular cells after hypoxia and reoxygenation using a hypoxia work station. RESULTS: Following IR injury in diabetic mice, the expression of PDK4, rather than the other PDK isoforms, was induced with a marked increase in pyruvate dehydrogenase E1alpha (PDHE1alpha) phosphorylation. This was accompanied by a pronounced ROS activation, as well as tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), interleukin-1beta (IL-1beta), and monocyte chemoattractant protein-1 (MCP-1) production. Notably, sodium dichloroacetate (DCA) attenuated renal IR injury-induced apoptosis which can be attributed to reducing PDK4 expression and PDHE1alpha phosphorylation levels. DCA or shPdk4 treatment reduced oxidative stress and decreased TNF-alpha, IL-6, IL-1beta, and MCP-1 production after IR or hypoxia-reoxygenation injury. CONCLUSION: PDK4 inhibition alleviated renal injury with decreased ROS production and inflammation, supporting a critical role for PDK4 in IR mediated damage. This result indicates another potential target for reno-protection during IR injury; accordingly, the role of PDK4 inhibition needs to be comprehensively elucidated in terms of mitochondrial function during renal IR injury. FAU - Khang, Ah Reum AU - Khang AR AD - Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea. FAU - Kim, Dong Hun AU - Kim DH AD - Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Korea. FAU - Kim, Min-Ji AU - Kim MJ AD - Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea. FAU - Oh, Chang Joo AU - Oh CJ AD - Research Institute of Aging and Metabolism, School of Medicine, Kyungpook National University, Daegu, Korea. FAU - Jeon, Jae-Han AU - Jeon JH AD - Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea. AD - Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Korea. FAU - Choi, Sung Hee AU - Choi SH AD - Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. FAU - Lee, In-Kyu AU - Lee IK AD - Research Institute of Aging and Metabolism, School of Medicine, Kyungpook National University, Daegu, Korea. AD - Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Korea. AD - Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea. LA - eng PT - Journal Article DEP - 20240201 PL - Korea (South) TA - Diabetes Metab J JT - Diabetes & metabolism journal JID - 101556588 SB - IM OTO - NOTNLM OT - Acute kidney injury OT - Diabetes mellitus OT - Inflammation OT - Ischemia OT - Pyruvate dehydrogenase kinase 4 OT - Reactive oxygen species OT - Reperfusion EDAT- 2024/02/05 00:42 MHDA- 2024/02/05 00:42 CRDT- 2024/02/04 19:28 PHST- 2023/06/22 00:00 [received] PHST- 2023/07/13 00:00 [accepted] PHST- 2024/02/05 00:42 [medline] PHST- 2024/02/05 00:42 [pubmed] PHST- 2024/02/04 19:28 [entrez] AID - dmj.2023.0196 [pii] AID - 10.4093/dmj.2023.0196 [doi] PST - aheadofprint SO - Diabetes Metab J. 2024 Feb 1. doi: 10.4093/dmj.2023.0196.